Gemmer Asset Management LLC Incyte Corp Transaction History

Gemmer Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$66.18 - $83.18 $661 - $831	-10 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$63.34 - $74.11 $633 - $741	10 New	10 $1,000
Q4 2019 Jan 17, 2020	SELL	$73.04 - $95.72 $219 - $287	-3 Closed	0 $0
Q3 2019 Oct 11, 2019	BUY	$72.82 - $86.52 $218 - $259	3 New	3 $0
Q2 2018 Jul 18, 2018	SELL	$60.85 - $83.98 $608 - $839	-10 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$83.06 - $100.98 $830 - $1,009	10 New	10 $1,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.